1992
DOI: 10.1002/eji.1830220104
|View full text |Cite
|
Sign up to set email alerts
|

Internalization of glycosyl‐phosphatidylinositol (GPI)‐anchored lymphocyte proteins II. GPI‐anchored and transmembrane molecules internalize through distinct pathways

Abstract: Ly-6A.2 (T cell-activating protein, TAP) and Thy-1 are glycosyl-phosphatidyl-inositol (GPI)-anchored proteins expressed on the surface of murine T lymphocytes. We have found that Ly-6A.2 (TAP) and Thy-1 are internalized by T cells. In the present study we have investigated whether these GPI-anchored proteins enter cells by endocytosis through coated pits. Two lines of evidence argue against the involvement of coated pits in the internalization of Ly-6A.2 (TAP) and Thy-1. First, drugs that effectively blocked t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
28
0

Year Published

1996
1996
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(30 citation statements)
references
References 39 publications
(13 reference statements)
2
28
0
Order By: Relevance
“…In lymphocytes. both types of proteins form caps when crosslinked, but only transmembrane proteins are endocytosed by coated pits (Bamezai et al, 1992). The structure through which GPI-anchored proteins are internalized has not been identified, but it might be a counterpart ofcaveolae.…”
Section: Discussionmentioning
confidence: 99%
“…In lymphocytes. both types of proteins form caps when crosslinked, but only transmembrane proteins are endocytosed by coated pits (Bamezai et al, 1992). The structure through which GPI-anchored proteins are internalized has not been identified, but it might be a counterpart ofcaveolae.…”
Section: Discussionmentioning
confidence: 99%
“…However, a dependence on internalization cannot be completely ruled out by any of the experiments to date. Even some GPI-anchored proteins become internalized upon treatment with activating antibodies (38 …”
Section: Discussionmentioning
confidence: 99%
“…In some experiments, the microfilamentdisrupting agent cytochalasin D (Sigma) (3 M), or the phosphoinositide-3 kinase inhibitor wortmannin (Calbiochem, San Diego, CA) (1 M) were added to the cells 30 min prior to the addition of LPS (33,34). After various times of LPS incubation, cells were washed and treated at 4°C with 200 g/ml Pronase (Boehringer Mannheim) for 1 h (35,36). Supernatants and cells were separated by centrifugation and transferred into scintillation liquid.…”
Section: Methodsmentioning
confidence: 99%